Who
Chad Thomas Campbell
SVP/GM, Vascular Access
Company insider
Files Form 4 as: SVP/GM, Vascular Access, AngioDynamics.
In numbers
- Trades disclosed
- 97
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $292K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 23 May 2017
- Last trade
- 22 Jul 2026
- Last filed
- 24 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 24 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code M | —6,466 at $0.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $32K2,330 at $13.82 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ANGO AngioDynamicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —22,768 at $0.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ANGO AngioDynamicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —22,768 at $0.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code M | —6,466 at $0.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $32K2,330 at $13.82 | filing |
| 20 Jul 2026filed 21 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $4,922359 at $13.71 | filing |
| 20 Jul 2026filed 21 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $4,922359 at $13.71 | filing |
| 17 Jul 2026filed 21 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $15K1,112 at $13.51 | filing |
| 17 Jul 2026filed 21 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $15K1,112 at $13.51 | filing |
| 16 Jul 2026filed 21 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $33K2,367 at $14.14 | filing |
| 16 Jul 2026filed 21 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $33K2,367 at $14.14 | filing |
| 15 Jul 2026filed 22 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code A | —16,081 at $0.00 | filing |
| 15 Jul 2026filed 22 Jul 2026 | ANGO AngioDynamicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,081 at $0.00 | filing |
| 15 Jul 2026filed 22 Jul 2026 | ANGO AngioDynamicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,081 at $0.00 | filing |
| 15 Jul 2026filed 22 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code A | —16,081 at $0.00 | filing |
| 21 Jul 2025filed 22 Jul 2025 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $3,551395 at $8.99 | filing |
| 20 Jul 2025filed 22 Jul 2025 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $3,120359 at $8.69 | filing |
| 19 Jul 2025filed 22 Jul 2025 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code F | $8,9071,025 at $8.69 | filing |
| 16 Jul 2025filed 18 Jul 2025 | ANGO AngioDynamicsoption or derivative · Medical Devices | SEC FORM 4 Code A | —26,268 at $0.00 | filing |
News
AngioDynamics (NASDAQ:ANGO) Given Buy Rating at Canaccord Genuity GroupANGO · themarketsdaily.com · 9 Oct 2026AngioDynamics (NASDAQ:ANGO) Issues FY 2027 Earnings GuidanceANGO · dailypolitical.com · 8 Oct 2026AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEOANGO · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Chad Thomas Campbell; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.